Meng Huihui, Xu Di, Wang Qing, Liu Lin, Liu Wenya, Wang Junsong
Center of Molecular Metabolism, School of Environmental & Biological Engineering, Nanjing University of Science and Technology, No. 200 Xiaolingwei Street, Nanjing 210094, China.
Department of Interventional Surgery, Zibo Central Hospital, No.54 Gongqingtuan Road (W), Zhangdian District, Zibo City, Shandong, China.
J Pharm Biomed Anal. 2023 Nov 30;236:115719. doi: 10.1016/j.jpba.2023.115719. Epub 2023 Sep 14.
Sepsis arises from an uncontrolled inflammatory response to infection that can lead to organ failure. The gut microbiome is increasingly recognized as a key modulator of sepsis progression. This study investigated whether Coptis chinensis water extract (CCWE) could attenuate sepsis by modulating the gut microbiome and immune response. A rat model of sepsis induced by cecum ligation and perforation was used. 16 S ribosomal ribonucleic acid (rRNA) sequencing, proton nuclear magnetic resonance (H NMR) metabolomics and flow cytometry assays were used to evaluate microbial, metabolic and immune profiles. CCWE treatment reversed sepsis-induced loss of beneficial bacteria like Firmicutes and Bacteroidetes and restored gut microbial balance. CCWE increased short-chain fatty acids, carnitine and phenylacetate, which provide energy and curb inflammation. By enhancing immune homeostasis and maintaining regulatory T cells (Tregs), CCWE treatment also exerted bidirectional regulation on T cells for initially suppressing hyperactivation then enabling recovery. Overall, CCWE may benefit sepsis by regulating the gut-microbiome-immune axis. By restoring microbiome balance, improving metabolism, and modulating immunity, CCWE treatment shows potential for alleviating sepsis severity and progression. The increases in beneficial bacteria, Tregs, and anti-inflammatory metabolites coupled with decreases in opportunistic pathogens likely contributed collectively to CCWE's protective effects. CCWE may emerge as an alternative or adjunctive option for managing disorders of dangerous inflammation like sepsis. Future research should explore CCWE's mechanisms of action clinically to determine its potential as a safe, effective means of modulating health through natural regulation of the gut microbiome and immune function.
脓毒症源于对感染的不受控制的炎症反应,可导致器官衰竭。肠道微生物群越来越被认为是脓毒症进展的关键调节因子。本研究调查了黄连水提取物(CCWE)是否能通过调节肠道微生物群和免疫反应来减轻脓毒症。采用盲肠结扎和穿孔诱导的大鼠脓毒症模型。使用16S核糖体核糖核酸(rRNA)测序、质子核磁共振(H NMR)代谢组学和流式细胞术分析来评估微生物、代谢和免疫特征。CCWE治疗逆转了脓毒症诱导的厚壁菌门和拟杆菌门等有益菌的损失,并恢复了肠道微生物平衡。CCWE增加了短链脂肪酸、肉碱和苯乙酸,这些物质提供能量并抑制炎症。通过增强免疫稳态和维持调节性T细胞(Tregs),CCWE治疗还对T细胞发挥双向调节作用,最初抑制过度激活,然后促进恢复。总体而言,CCWE可能通过调节肠道微生物群-免疫轴使脓毒症受益。通过恢复微生物群平衡、改善代谢和调节免疫,CCWE治疗显示出减轻脓毒症严重程度和进展的潜力。有益菌、Tregs和抗炎代谢物的增加,以及机会性病原体的减少,可能共同促成了CCWE的保护作用。CCWE可能成为治疗脓毒症等危险炎症疾病的替代或辅助选择。未来的研究应在临床上探索CCWE的作用机制,以确定其作为一种通过自然调节肠道微生物群和免疫功能来调节健康的安全、有效手段的潜力。